MIST — Milestone Pharmaceuticals Inc.
MIST dilution and offerings
- Active shelf: S-3 (May 2026)
- Float: 110.0M shares
Dilution filings
- S-3
- S-3
🔔 Alert me if MIST files an offering or S-3
$0.7593+5.30%
Last close: · regular session
Pre-market $0.7593 0.00% ·
Last 60 sessions
Active shelf registration (S-3, May 2026). Float: 110.0M shares. Latest SEC filing: 8-K on Oct 28, 2026. MIST closed at $0.7593 (+5.30%) on Nov 3, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for MIST in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: CA
- Exchange: NASDAQ
- Employees: 33
- Website: https://www.milestonepharma.com
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
Latest SEC filings for MIST
Latest MIST news
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read article
- Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.